NCT05371028View on ClinicalTrials.gov

A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

CompletedOBSERVATIONAL

Enrollment

52

Participants

Timeline

Start Date

September 23, 2023

Primary Completion Date

February 19, 2025

Study Completion Date

February 19, 2025

Conditions

Short Bowel Syndrome (SBS)

Interventions

OTHER

Non-interventional Study

This is non-interventional study.

Trial Locations (1)

L6L 0C4

Innomar Strategies, Oakville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY